Guilin Sanjin Pharmaceutical Co., Ltd. at its Annual General Meeting of 2022 held on 19 May 2023, approved cash dividend/10 shares (tax included): CNY 4.00000000.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.06 CNY | -2.17% | -2.17% | -9.87% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.87% | 1.06B | |
+41.52% | 6.2B | |
-23.06% | 4.09B | |
+11.98% | 3.48B | |
-19.68% | 2.82B | |
-11.52% | 2.28B | |
+45.53% | 1.94B | |
-8.31% | 1.51B | |
+48.41% | 1.53B | |
-19.16% | 1.47B |
- Stock Market
- Equities
- 002275 Stock
- News Guilin Sanjin Pharmaceutical Co., Ltd.
- Guilin Sanjin Pharmaceutical Co., Ltd. Approves Cash Dividend for 2022